{"schema_version":"secwatch.filing_event.v1","accession":"0001728117-26-000054","form_type":"8-K","ticker":"GOSS","cik":"0001728117","company_name":"Gossamer Bio, Inc.","filed_at":"2026-06-17T12:01:14+00:00","discovered_at":"2026-06-17T12:05:00.428960+00:00","generated_at":"2026-06-17T12:05:48.340461+00:00","sec_items":["7.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Gossamer Bio completes exchange of 94.5% of 2027 notes; $18.9M remain outstanding","bullets":["$181.1M principal (94.5%) of 5% 2027 notes tendered; exchanged for new 7.5% 2030 notes and equity.","Company lowered tender condition from 98% to 90.5% after sufficient early participation by June 2.","Early settlement occurred June 4; supplemental indenture eliminated restrictive covenants.","No additional notes tendered after early date; $18.9M of existing notes remain outstanding.","New 7.5% secured first lien notes due 2030, plus up to 317.6M shares or prefunded warrants issued."],"urls":{"canonical":"https://secwatch.observer/filing/0001728117-26-000054","json":"https://secwatch.observer/filing/0001728117-26-000054.json","markdown":"https://secwatch.observer/filing/0001728117-26-000054.md","text":"https://secwatch.observer/filing/0001728117-26-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000054/0001728117-26-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000054/goss-20260617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T12:05:48.340461+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}